Clinical Trial Update: A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects [Phase 3]

View source ↗

Summary

A multicenter Phase 3 trial evaluated interferon-beta-1a for chronic hepatitis C in Asian subjects. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon beta-1a (Interferon beta-1a)

Snippet

Sponsor: EMD Serono | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED